Geneesmiddelenbeleid

This procedure concerns the Dutch government's policy on medicines. It involves a written consultation within the House of Representatives, indicating a discussion on current or proposed regulations and strategies related to pharmaceutical products. The focus is on how the government plans to manage and regulate medicines, potentially impacting patients, healthcare providers, and the pharmaceutical industry within the Netherlands.